نمایش پرونده ساده آیتم

dc.contributor.authorSoufi, FG
dc.contributor.authorSheervalilou, R
dc.contributor.authorVardiani, M
dc.contributor.authorKhalili, M
dc.contributor.authorAlipour, MR
dc.date.accessioned2018-08-26T08:38:52Z
dc.date.available2018-08-26T08:38:52Z
dc.date.issued2012
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52971
dc.description.abstractobjective. Te present study was designed to evaluate whether long-term resveratrol administration has beneficial effects on the metabolic control and oxidative stress in diabetic rats. Methods. Male Wistar rats were divided into four groups: normal control, diabetic control, normal treated with resveratrol, and diabetic treated with resveratrol. Diabetes was induced by injection of streptozotocin (50 mg/kg; i.p.), fifteen minutes after the administration of nicotinamide (110 mg/ kg; i.p.) in 12 h fasted rats. results. Four-month oral resveratrol administration (5 mg/kg/day) significantly attenuated the elevated levels of the blood glucose, glycosylated hemoglobin, total protein, albumin, urea, creatinine, and 8-isoprostane in diabetic rats. Moreover, resveratrol administration to diabetic rats improved the reduced levels of glutathione, total antioxidant capacity, and the antioxidant enzymes activities (superoxide dismutase, glutathione peroxidase, and catalase). No significant differences were observed in the activities of plasma aminotransferases (ALT and AST) and insulin levels between diabetic rats treated with resveratrol and diabetic controls. Conclusion. Te results suggest that chronic resveratrol administration is safe and effective, and may be considered as a beneficial therapeutic compound in diabetes.
dc.language.isoEnglish
dc.relation.ispartofEndocrine Regulations
dc.subject8 isoprostane
dc.subjectalbumin
dc.subjectcatalase
dc.subjectcreatinine
dc.subjectglucose
dc.subjectglutathione
dc.subjectglutathione peroxidase
dc.subjecthemoglobin A1c
dc.subjectresveratrol
dc.subjectsuperoxide dismutase
dc.subjecturea
dc.subjectalanine aminotransferase
dc.subjectantioxidant
dc.subjectaspartate aminotransferase
dc.subjectcatalase
dc.subjectglutathione peroxidase
dc.subjectglutathione peroxidase 1
dc.subjectresveratrol
dc.subjectstilbene derivative
dc.subjectsuperoxide dismutase
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectantioxidant activity
dc.subjectarticle
dc.subjectcontrolled study
dc.subjectELISA kit
dc.subjectmale
dc.subjectmetabolic regulation
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectnonhuman
dc.subjectoral glucose tolerance test
dc.subjectoxidative stress
dc.subjectrat
dc.subjectspectrophotometry
dc.subjectweight change
dc.subjectanimal
dc.subjectblood
dc.subjectdisease model
dc.subjectdrug effect
dc.subjectexperimental diabetes mellitus
dc.subjecthyperglycemia
dc.subjectmetabolism
dc.subjectWistar rat
dc.subjectAlanine Transaminase
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectAspartate Aminotransferases
dc.subjectCatalase
dc.subjectDiabetes Mellitus, Experimental
dc.subjectDiabetes Mellitus, Type 2
dc.subjectDisease Models, Animal
dc.subjectGlutathione Peroxidase
dc.subjectHyperglycemia
dc.subjectMale
dc.subjectOxidative Stress
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectStilbenes
dc.subjectSuperoxide Dismutase
dc.titleChronic resveratrol administration has beneficial effects in experimental model of type 2 diabetic rats
dc.typeArticle
dc.citation.volume46
dc.citation.issue2
dc.citation.spage83
dc.citation.epage90
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.4149/endo_2012_02_83


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم